Abstract
This paper describes a new class of immuno-targeted and cancer specific CT contrast agents, which enable CT imaging of cancer at cellular and molecular resolution. The method is based on the development of gold nano-probes that specifically and sensitively target in vivo tumor specific antigens, while inducing distinct contrast in CT imaging (increased x-ray attenuation). The overall goal of this research is to develop a novel cancer imaging tool, which may lead to improvements in therapy due to early detection, accurate staging and micro-tumor identification.
| Original language | English |
|---|---|
| Title of host publication | Technical Proceedings of the 2008 NSTI Nanotechnology Conference and Trade Show, NSTI-Nanotech, Nanotechnology 2008 |
| Pages | 5-7 |
| Number of pages | 3 |
| State | Published - 2008 |
| Externally published | Yes |
| Event | 2008 NSTI Nanotechnology Conference and Trade Show, NSTI Nanotech 2008 Joint Meeting, Nanotechnology 2008 - Quebec City, QC, United States Duration: 1 Jun 2008 → 5 Jun 2008 |
Publication series
| Name | Technical Proceedings of the 2008 NSTI Nanotechnology Conference and Trade Show, NSTI-Nanotech, Nanotechnology 2008 |
|---|---|
| Volume | 2 |
Conference
| Conference | 2008 NSTI Nanotechnology Conference and Trade Show, NSTI Nanotech 2008 Joint Meeting, Nanotechnology 2008 |
|---|---|
| Country/Territory | United States |
| City | Quebec City, QC |
| Period | 1/06/08 → 5/06/08 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- CT contrast agents
- Gold nanoparticles
- In-vivo cancer imaging
Fingerprint
Dive into the research topics of 'Gold nano-probes as targeted CT contrast agents for in-vivo cancer imaging'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver